| 09/14/2026 7:00 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 6:00 AM | Bain Capital Life Sciences Opportunities III, LP (1950105) Filed by Cabaletta Bio (1759138) Subject | Form SCHEDULE 13G/A | |
| 08/13/2026 6:32 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2026 6:34 AM | Cabaletta Bio (1759138) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/12/2026 11:06 AM | Adage Capital Management, L.P. (1535978) Filed by Cabaletta Bio (1759138) Subject | Form SCHEDULE 13G/A | |
| 08/12/2026 5:36 AM | Cabaletta Bio (1759138) Subject NORGES BANK (1374170) Filed by | Form SCHEDULE 13G | |
| 07/31/2026 8:55 AM | Cabaletta Bio (1759138) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 07/23/2026 4:27 PM | Cabaletta Bio (1759138) Subject MILLENNIUM MANAGEMENT LLC (1273087) Filed by | Form SCHEDULE 13G/A | |
| 06/11/2026 6:01 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/10/2026 5:54 PM | Bollard Catherine (1790411) Reporting Cabaletta Bio (1759138) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 5:56 PM | Cabaletta Bio (1759138) Issuer HENRIQUES RICHARD C JR (1181178) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CABA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cabaletta Bio and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/10/2026 5:59 PM | Cabaletta Bio (1759138) Issuer Simon Mark (1400717) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 6:04 PM | Cabaletta Bio (1759138) Issuer Tomasello Shawn (1617239) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 5:51 PM | Brun Scott C. (1863614) Reporting Cabaletta Bio (1759138) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2026 1:09 PM | Cabaletta Bio (1759138) Subject PRUDENTIAL FINANCIAL INC (1137774) Filed by | Form SCHEDULE 13G/A | |
| 06/04/2026 3:18 PM | Cabaletta Bio (1759138) Subject JENNISON ASSOCIATES LLC (53417) Filed by | Form SCHEDULE 13G/A | |
| 06/03/2026 6:02 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/01/2026 6:30 AM | Cabaletta Bio (1759138) Filer | Form DEFA14A | |
| 05/15/2026 12:20 PM | Cabaletta Bio (1759138) Subject Cormorant Asset Management, LP (1583977) Filed by | Form SCHEDULE 13G/A | |
| 05/14/2026 6:08 AM | Cabaletta Bio (1759138) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/14/2026 6:02 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/14/2026 6:06 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 5:37 AM | Cabaletta Bio (1759138) Filer | Form 424B5 | |
| 05/04/2026 5:40 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 5:02 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/28/2026 6:41 AM | Cabaletta Bio (1759138) Filer | Form ARS | |
| 04/28/2026 6:31 AM | Cabaletta Bio (1759138) Filer | Form DEF 14A | |
| 04/28/2026 6:35 AM | Cabaletta Bio (1759138) Filer | Form DEFA14A | |
| 04/20/2026 6:01 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 6:45 AM | Cabaletta Bio (1759138) Filer | Form PRE 14A | |
| 03/23/2026 6:36 AM | Cabaletta Bio (1759138) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/23/2026 6:42 AM | Cabaletta Bio (1759138) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/23/2026 6:32 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/02/2026 6:28 PM | Cabaletta Bio (1759138) Issuer Das Arun (1903997) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 6:27 PM | Cabaletta Bio (1759138) Issuer Gerard Michael (1881529) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 6:18 PM | Cabaletta Bio (1759138) Issuer Marda Anup (1790410) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 6:21 PM | Cabaletta Bio (1759138) Issuer Nichtberger Steven (1487989) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 6:24 PM | Cabaletta Bio (1759138) Issuer Chang David J. (1790552) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 6:26 PM | Binder Gwendolyn (1791742) Reporting Cabaletta Bio (1759138) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 2:00 PM | Cabaletta Bio (1759138) Subject Cormorant Asset Management, LP (1583977) Filed by | Form SCHEDULE 13G/A | |
| 02/17/2026 9:28 AM | Cabaletta Bio (1759138) Subject T. Rowe Price Investment Management, Inc. (1897612) Filed by | Form SCHEDULE 13G/A | |
Wall Street legend reveals his top AI stock before Oct. 20 (Ad) Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock ahead of October 20. His system has spotted at least seven of the top 10 performers every year since 2016, including all ten in the 2022 bear market and every member of the Magnificent Seven before their run higher.
Now Chaikin's Power Gauge is turning bullish on an under-the-radar company tied to next-generation AI data centers built under Executive Order 14363, technology he says uses 99 percent less electricity and space while offering far greater computing power. Watch the free interview now to see Chaikin's top AI stock pick |
| 01/21/2026 5:53 PM | Cabaletta Bio (1759138) Issuer Gerard Michael (1881529) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 5:53 PM | Cabaletta Bio (1759138) Issuer Simon Mark (1400717) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 5:54 PM | Cabaletta Bio (1759138) Issuer Nichtberger Steven (1487989) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 5:54 PM | Bollard Catherine (1790411) Reporting Cabaletta Bio (1759138) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 5:55 PM | Cabaletta Bio (1759138) Issuer Gavel Steve (2090785) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 5:55 PM | Cabaletta Bio (1759138) Issuer Tomasello Shawn (1617239) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 5:56 PM | Binder Gwendolyn (1791742) Reporting Cabaletta Bio (1759138) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 5:56 PM | Cabaletta Bio (1759138) Issuer Chang David J. (1790552) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 7:02 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 7:06 PM | Alyeska Investment Group, L.P. (1453072) Filed by Cabaletta Bio (1759138) Subject | Form SCHEDULE 13G/A | |
| 11/14/2025 12:10 PM | Cabaletta Bio (1759138) Subject Cormorant Asset Management, LP (1583977) Filed by | Form SCHEDULE 13G/A | |
| 11/10/2025 6:33 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/10/2025 6:37 AM | Cabaletta Bio (1759138) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/07/2025 12:56 PM | Cabaletta Bio (1759138) Subject PRUDENTIAL FINANCIAL INC (1137774) Filed by | Form SCHEDULE 13G/A | |
| 11/07/2025 12:00 PM | Cabaletta Bio (1759138) Subject T. Rowe Price Investment Management, Inc. (1897612) Filed by | Form SCHEDULE 13G/A | |
| 11/07/2025 12:02 PM | Cabaletta Bio (1759138) Subject T. Rowe Price Investment Management, Inc. (1897612) Filed by | Form SCHEDULE 13G/A | |
| 11/05/2025 12:26 PM | Cabaletta Bio (1759138) Subject JENNISON ASSOCIATES LLC (53417) Filed by | Form SCHEDULE 13G/A | |
| 10/29/2025 6:01 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/27/2025 6:02 AM | Cabaletta Bio (1759138) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/15/2025 3:31 PM | Cabaletta Bio (1759138) Issuer Gavel Steve (2090785) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/15/2025 3:39 PM | Cabaletta Bio (1759138) Issuer Gavel Steve (2090785) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |